Lv1
50 积分 2023-11-06 加入
[Impact of different diagnostic criteria for assessing mild micro-hepatic encephalopathy in liver cirrhosis: an analysis based on a prospective, multicenter, real-world study]
10个月前
已完结
Liver steatosis and fibrosis in China
1年前
已完结
Liver steatosis and fibrosis in China
1年前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
1年前
已完结
NASH drug treatment development: challenges and lessons
1年前
已完结
Implementation of a liver health check in people with type 2 diabetes
1年前
已完结
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study
1年前
已完结
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
1年前
已完结
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
1年前
已完结
Reply to: “Non-invasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cut-off values”
1年前
已完结
皖公网安备34019202002308
